Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00877006 |
|---|---|
| Brief Title: | Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study |
| First Submitted : | April 3, 2009 |
| First Submitted that Met QC Criteria : | April 6, 2009 |
| First Posted : | April 7, 2009 (Estimate) |
| Results First Submitted : | March 25, 2014 |
| Results First Submitted that Met QC Criteria : | March 25, 2014 |
| Results First Posted : | April 28, 2014 (Estimate) |
| Certification/Extension First Submitted : | August 8, 2013 |
| Certification/Extension First Submitted that Met QC Criteria : | August 8, 2013 |
| Certification/Extension First Posted : | August 20, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 8, 2018 |
| Last Update Posted : | February 5, 2018 |